Meningiomas are the most common primary intracranial tumors, with a frequency of about 30% - 40% of benign brain tumors [1]. In the literature, a female predominance has been described [1]. This suggests the involvement of hormonal factors in their pathophysiology [1]. Although most meningiomas are benign and develop slowly, remarkable cases of accelerated tumor growth during pregnancy have been reported, associated with the presence of hormone receptors, particularly progesterone, on tumor cells [2].

The association of a meningioma with pregnancy is a rare case; some authors report a frequency of 0.001%, but this association is clinically significant [3].

Diagnosis may be delayed or misdiagnosed because neurological symptoms (headache, dizziness, vomiting, focal deficits, and seizures) may be attributed to classic manifestations of pregnancy or pregnancy-related complications such as preeclampsia or eclampsia [4].

Systematic reviews and case series indicate that pregnancy can influence the course of meningiomas due to hormonal and hemodynamic changes, sometimes leading to rapid tumor growth or increased peri-lesional edema, requiring multidisciplinary management [5].

In our context of resource-limited countries, delayed access to brain imaging and the scarcity of local data on the management of meningiomas during pregnancy further complicate clinical management. Recent clinical reports, including cases documented in African contexts, emphasize the importance of early diagnosis, coordination between obstetrician-gynecologists, neurosurgeons, neonatal pediatricians, and intensive care anesthesiologists for adaptation of therapeutic strategies [6][7].

The management of cerebral meningiomas during pregnancy remains complex and non-consensual. It is based on a multidisciplinary evaluation integrating gestational age, the severity of neurological signs, tumor location and the risks associated with surgical or anesthetic interventions. The choice between a conservative attitude, symptomatic medical treatment, emergency or deferred neurosurgery, and planning of the period and route of delivery requires consideration of maternal complications and fetal viability [6][7]. It is in this context of multidisciplinary management that we report the case of a patient with a meningioma associated with pregnancy, whom we followed and managed, followed by a review of the literature in order to better understand the epidemiological, diagnostic, therapeutic and maternal and fetal outcomes aspects of this rare association.

For ethical reasons, written informed consent for the publication of this case report and the associated data was obtained from the patient’s next of kin. The patient’s identity was protected to ensure confidentiality.

We report the case of a 34-year-old patient, G3P2, mother of two living children, who consulted at the Department of Gynecology-Obstetrics and Reproductive Medicine of the Souro Sanou University Hospital Center (CHU-SS) of Bobo-Dioulasso.

The coexistence of a cerebral meningioma and pregnancy is a rare but potentially serious situation, exposing to maternal neurological complications and high perinatal morbidity and mortality [1]. The reported case illustrates the decision-making complexity and limits of care in a context with limited resources.

Meningiomas occur preferentially in women of childbearing age, suggesting a hormonal influence on their development and evolution. Several studies have shown that the majority of meningiomas express progesterone receptors, and that hormonal variations during pregnancy, associated with hypervolemia and sodium retention, can promote rapid tumor growth or increased peritumoral edema [5]. Some authors confirm this exacerbation of neurological symptoms in the patient [4][8]. These pathophysiological mechanisms explain the neurological worsening observed in some previously asymptomatic patients, such as the case of our patient. These tumors tend to grow slowly; however, pregnancy seems to accelerate this process, causing symptoms, through hormonal mechanisms such as progesterone [5]. Regarding the influence of the tumor on pregnancy, the literature reports an exacerbation of symptoms at the maternal level such as headache, vomiting, neurological signs such as motor deficits, and disturbances of consciousness [2][4][5]. These signs were found in our patient. Also the evolution of the tumor can be the cause of growth retardation, prematurity [4]. This was the case for the patient presented.

The management of meningiomas associated with pregnancy is uncodified and remains a particular challenge for neurosurgeons and obstetricians. It is based on several parameters, including the severity of neurological signs, gestational age, tumor location and the availability of specialized resources [9]. When maternal neurological status is stable, a conservative approach with close monitoring until fetal viability is usually preferred.

A pregnancy in a patient with a meningioma leads the neurosurgeon to question whether to operate immediately or to wait until the end of the pregnancy. As far as the obstetrician is concerned, the challenge remains the reciprocal influence of the tumor and the pregnancy.

In cases of severe neurological deficit or if the size of the tumor is likely to lead to brain engagement, the procedure is considered an emergency. The difficulty arises in the case of advanced pregnancy, where a risk of fetal harm exists [10]. In our case, the continuation of the pregnancy until 32 weeks of amenorrhea allowed fetal extraction in a context of worsening maternal symptoms.

VijayMRavindra and colleagues reported a case of a brain tumor associated with pregnancy that was managed appropriately. The cesarean delivery was performed at 39 weeks of gestation, resulting in a favorable neonatal outcomes [9]. In contrast, in our case, the worsening maternal complications precluded continuation of the pregnancy until fetal maturity, leading to an emergency cesarean delivery at 32 weeks of gestation.

Caesarean section is often recommended in patients with symptomatic meningioma, especially if intracranial hypertension is suspected, to avoid expulsive efforts and the risk of neurological decompensation during labor [11]. This strategy was adopted in our observation.

Despite a satisfactory initial Apgar score, the neonatal course was unfavorable with one secondary death due to respiratory distress. This outcome is mainly linked to prematurity, a major factor in neonatal mortality, particularly in low-income countries where access to effective neonatal resuscitation remains limited [12].

The immediate maternal evolution after delivery was favorable, allowing a delayed tumor resection to 45 days postpartum. This approach is supported by several authors, who recommend, when possible, postponing surgery after childbirth in order to reduce the anesthetic, bleeding, and obstetric risks associated with pregnancy [9][13]. However, despite surgical management, the subsequent course was marked by the death of the patient.

This adverse outcome underscores the potential severity of pregnancy in patients with meningiomas. The frequency of postoperative complications in settings where neurosurgical intensive care, specialized postoperative follow-up and follow-up imaging may be insufficient. Factors such as persistent cerebral edema, metabolic disorders, or uncontrolled intracranial hypertension may contribute to late mortality [14].

Several constraints worsen the prognosis of patients with meningioma during pregnancy: delay in diagnosis due to limited access to MRI, clinical confusion with sympathetic signs of pregnancy or other obstetric pathologies such as preeclampsia and eclampsia. Insufficient multidisciplinary coordination, and low maternal and neonatal resuscitation capacity [15]. Published African data remain scarce, which gives case reports particular value in documenting local realities and improving management strategies. However, the main limitation of this study is its descriptive nature based on a single case report. This observation does not allow the generalization of findings or the establishment of universal recommendations. Nevertheless, this case highlights the diagnostic, therapeutic, and prognostic challenges of meningioma during pregnancy in our setting. It also underscores the limited access to specialized imaging and intensive neonatal care.

This case highlights the need for close collaboration between obstetricians, neurologists, neurosurgeons, anesthesiologist and neonatologists, as well as the importance of strengthening health systems. Improved access to brain imaging, specialized neurosurgery, and neonatal intensive care could significantly improve maternal-fetal prognosis in this type of situation.

The occurrence of an intracranial meningioma during pregnancy is a rare but serious clinical situation, involving the maternal and fetal prognosis. This observation illustrates the diagnostic and therapeutic complexity of brain tumors in pregnant women. The clinical presentation may be atypical or simulated for certain obstetric pathologies.

Management is based on a multidisciplinary approach involving obstetricians, neurosurgeons and anesthetists, with a rigorous assessment of the benefit-risk ratio for the mother and the fetus.

However, despite appropriate care, the evolution can be unfavorable, as evidenced by the maternal and neonatal mortality observed in this case. This case illustrates the potential severity of this pathological association.